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ABSTRACT
Background: Epidemiologic studies have shown dietary antiox-
idants to be inversely correlated with ischemic heart disease.
Objective: We investigated whether dietary b-carotene, vitamin C,
and vitamin E were related to the risk of myocardial infarction
(MI) in an elderly population.
Design: The study sample consisted of 4802 participants of the
Rotterdam Study aged 55–95 y who were free of MI at baseline
and for whom dietary data assessed by a semiquantitative food
frequency questionnaire were available. During a 4-y follow-up
period, 124 subjects had an MI. The association between energy-
adjusted b-carotene, vitamin C, and vitamin E intakes and risk of
MI was examined by multivariate logistic regression.
Results: Risk of MI for the highest compared with the lowest ter-
tile of b-carotene intake was 0.55 (95% CI: 0.34, 0.83; P for
trend = 0.013), adjusted for age, sex, body mass index, pack-years,
income, education, alcohol intake, energy-adjusted intakes of vit-
amin C and E, and use of antioxidative vitamin supplements.
When b-carotene intakes from supplements were considered, the
inverse relation with risk of MI was slightly more pronounced.
Stratification by smoking status indicated that the association was
most evident in current and former smokers. No association with
risk of MI was observed for dietary vitamin C and vitamin E.
Conclusion: The results of this observational study in the elderly
population of the Rotterdam Study support the hypothesis that
high dietary b-carotene intakes may protect against cardiovascu-
lar disease. We did not observe an association between vitamin C
or vitamin E and MI. Am J Clin Nutr 1999;69:261–6.
KEY WORDS Myocardial infarction, ischemic heart dis-
ease, dietary antioxidants, b-carotene, vitamin C, vitamin E, vit-
amin supplements, elderly, the Rotterdam Study, Netherlands
INTRODUCTION
Several epidemiologic studies have shown dietary antioxidants to
be inversely associated with ischemic heart disease (1–9). The
antioxidants b-carotene, tocopherol, and vitamin C have been impli-
cated in preventing or slowing down the atherosclerotic process by
inhibiting LDL oxidation. The most consistent and reliable associa-
tion has been seen with vitamin E, either with supplementation or
with relatively high dietary intakes. b-Carotene and vitamin C
intakes have been less clearly associated with a reduced risk of
ischemic heart disease (10). Most epidemiologic studies of dietary
antioxidants and risk of ischemic heart disease have focused on
middle-aged populations. In the present study we investigated
whether dietary intakes of the antioxidants b-carotene, vitamin C,
and vitamin E are related to the risk of myocardial infarction (MI)
in an elderly population. 
SUBJECTS AND METHODS
Study population
The Rotterdam Study is a community-based, prospective
cohort study of 7983 persons (response rate 78%) aged ‡ 55 y liv-
ing in Ommoord, an urban district in Rotterdam, Netherlands.
The aim of the study is to investigate the incidence of and the risk
factors for chronic and disabling cardiovascular, neurodegenera-
tive, locomotor, and ophthalmic diseases, as described elsewhere
(11). The study was approved by the Medical Ethics Committee
of Erasmus University, and written, informed consent was
obtained from all participants. Follow-up for ischemic heart dis-
ease mortality started after the baseline survey in 1990 and fol-
low-up information was available for 94% of the cohort until
April 1996. Of the 5159 subjects with dietary data, 173 subjects
had an MI during the follow-up period. Because of possible
changes in dietary patterns, subjects with a previously known MI
at baseline (n = 357) were excluded from the analysis. Thus, 4802
subjects made up the current analysis. During an average follow-
up time of 4 y, 124 cases of first fatal or nonfatal MI occurred.
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Case ascertainment
The duration of the follow-up period, starting at the baseline
examination and lasting until April 1996 for the present analysis,
was 3–7 y (x–: 4 y). The vital status (eg, change of address or
death) of participants’ information was obtained at regular inter-
vals from the municipal health service in Rotterdam. Information
on fatal and nonfatal endpoints for 85% of the cohort was
obtained from the general practitioners (GPs) in the study district
of Ommoord, who regularly report such information to the data
center of the Rotterdam Study. All possible myocardial infarc-
tions by the GPs were verified by research physicians from the
Rotterdam Study by analyzing the records of the participating
practitioners and medical specialists. In April 1996, the medical
records of the 15% of the cohort with GPs from outside the
Ommoord area were checked by research physicians; additional
information was collected for all possible myocardial infarctions.
In the case of death, causes and circumstances were determined
by examining hospital-discharge records and by questioning the
GPs. Follow-up information was available for 94% of the cohort.
Classification of fatal and nonfatal events was based on the
International Classification of Diseases (ICD) (12). Cases of first
nonfatal or fatal MIs (ICD-10:I21-I24) were selected and classi-
fied independently by 2 research physicians. If there was dis-
agreement, a consensus was reached in a special session. All
events were verified by a medical expert in the field of cardio-
vascular disease, whose judgment was considered final.
Measurements
Baseline information on current health status, medical history,
drug use, education level, income, and smoking behavior was
obtained with a computerized semiquantitative food-frequency ques-
tionnaire (SFFQ) during a home interview. Height and weight were
measured and body mass index [BMI; wt (in kg)/ht2(in m)] was cal-
culated as a measure of obesity. Sitting blood pressure (BP) was
measured in the right upper arm with a random-zero sphygmo-
manometer; the average of 2 measurements was used. Subjects were
considered to be hypertensive if they had a systolic BP ‡ 140 mm Hg,
had a diastolic BP ‡ 90 mm Hg, or used antihypertensive drugs. A
venipuncture was performed and serum total and HDL-cholesterol
concentrations were determined with an automated enzymatic pro-
cedure. Subjects were classified as hypercholesterolemic if their
serum cholesterol concentrations were ‡ 6.5 mmol/L.
Dietary assessment
The SFFQ completed at baseline aimed to assess habitual
food intakes during the past year and included 170 food items in
13 food groups and questions about dietary habits, supplementa-
tion, and prescribed diets. The dietary assessment consisted of a
simple self-administered questionnaire that was completed at
home (completion time: <20 min) and a subsequent structured
interview with a trained dietitian (time allocated: <20 min). The
structured interview was based on the contents of the completed
questionnaire and was conducted during the subjects’ second
visit to the study center. The SFFQ data were converted to nutri-
ent intakes by using the computerized Dutch Food Composition
Table (13). Data for b-carotene, retinol, and tocopherol were
updated by using an additional database of the Netherlands Insti-
tute of Public Health and Environmental Protection (YCJ Volle-
bregt and EJM Feskens, unpublished observations, 1993). Nutri-
tional supplement intakes were not considered because dose and
duration were not recorded with sufficient accuracy.
The validity of the SFFQ was assessed in a subsample of 80 men
and women aged 55–75 y. Nutrient intakes estimated from the SFFQ
were compared with estimated nutrient intakes from food records
completed on 15 d and collected over 1 y (14). The ability of the
SFFQ to rank subjects adequately according to their dietary intakes
was demonstrated by Pearson’s correlation coefficients of 0.4–0.8
adjusted for sex, age, total energy intake (15), and within-person vari-
ability in daily intakes (16), and a high degree of classification into the
same or an adjacent quintile (76.8% for energy-adjusted data).
Data analysis
All analyses were performed for men and women combined.
Energy-adjusted nutrient intakes were derived by adding the
median nutrient intake to the residuals from regression analysis
of nutrients on energy intake (15). The association between
energy-adjusted antioxidants and risk of MI was examined pri-
marily by multivariate logistic regression. Because vitamins can
be ingested from both foods and supplements, exposure to each
vitamin was studied in 2 ways.
First, dietary antioxidant intakes from food sources were catego-
rized into tertiles and the risk of MI in the highest and middle tertiles
was compared with the risk of MI in the lowest tertile. The initial
analysis examined associations adjusted for age and sex. Further-
more, the analyses were adjusted for BMI, pack-years (average num-
ber of packs of cigarettes smoked times the number of years smoked),
equivalent household income (5 categories), highest education
attained (5 categories), and alcohol intake (5 categories). Supplement
preparations containing b-carotene, vitamin C, or vitamin E were
combined and added to the model as a separate variable. This allowed
investigation of the relation between dietary antioxidants and the risk
of MI unconfounded by supplemental antioxidant vitamin intake.
Second, to simultaneously study the effects of antioxidants from
food sources and supplement preparations, users of b-carotene, vita-
min C, vitamin E, or multivitamin supplements were categorized into
the highest tertile of the correspondent dietary intake. The age- and
sex-adjusted risk of MI according to tertile of intake was investigated
and the models were subsequently adjusted for the above-mentioned
factors, except for supplemental antioxidant intakes. The associations
between tertiles of energy-adjusted b-carotene, vitamin E, and vita-
min C with risk of MI were expressed as odds ratios with 95% CIs.
Results were considered significantly different at the two-sided 0.05
a level. Statistical analysis was performed by using SAS software
(release 6.11; SAS Institute, Cary, NC).
RESULTS
The mean ( – SD) age of the 1856 men and 2946 women was
67.0 – 7.3 and 67.9 – 8.0 y, respectively. Compared with the gen-
eral population of the Rotterdam Study for whom dietary data
were available (n = 5434), the study population for the present
analysis did not differ significantly in characteristics such as age,
BMI, blood pressure, income, education level, or nutrient intake.
Vitamin supplements containing either b-carotene, vitamin C, or
vitamin E were used by 11.8% of the study population.
Details of the association between intakes of energy-adjusted
antioxidants and selected baseline characteristics are presented in
Table 1. Because sex and age were not equally distributed across
tertiles of dietary antioxidant intake, age and sex were adjusted
for. Mean energy-adjusted dietary intakes of b-carotene were 0.84
mg/d in the lowest and 2.11 mg/d in the highest tertile, of vitamin
C were 63 mg/d in the lowest tertile and 170 mg/d in the highest
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TABLE 1
Baseline characteristics by tertile of energy-adjusted dietary b-carotene, vitamin E, and vitamin C intakes1
Energy-adjusted dietary b-carotene Energy-adjusted dietary vitamin E Energy-adjusted dietary vitamin C
1 (lowest) 2 3 (highest) P 1 (lowest) 2 3 (highest) P 1 (lowest) 2 3 (highest) P
< 1.13 mg/d 1.13–1.57 mg/d > 1.57 mg/d for <10.2 mg/d 10.2–14.2 mg/d > 14.2 mg/d for < 87 mg/d 87–126 mg/d > 126 mg/d for
(n = 1601) (n = 1601) (n = 1600) trend (n = 1601) (n = 1601) (n = 1600) trend (n = 1601) (n = 1601) (n = 1600) trend
BMI (kg/m2) 26.0 26.4 26.3 0.011 26.3 26.3 26.1 0.323 26.0 26.2 26.5 0.003
Current smokers (%) 29.1 25.9 19.5 0.015 27.6 25.4 21.7 0.007 31.4 22.8 20.0 0.001
Hypertension (%)2 48.4 48.3 49.0 0.610 48.6 48.5 48.6 0.330 47.3 49.9 48.5 0.381
Hypercholesteremia (%)3 52.5 48.0 49.0 0.063 51.3 48.8 49.5 0.212 52.0 49.9 47.5 0.786
Diabetes (%) 9.5 9.3 9.0 0.631 8.0 9.8 9.7 0.170 10.2 9.6 7.9 0.052
Alcohol intake (mg/d) 12.1 10.9 10.9 0.021 14.1 10.5 9.7 <0.001 12.0 11.6 10.3 0.002
Antioxidative vitamin 
supplementation (%)4 11.0 11.5 11.3 0.651 10.3 11.9 11.5 0.577 11.6 10.9 11.3 0.482
Energy-adjusted 
vitamin C intake (mg/d) 93.8 108.7 132.8 <0.001 1.27 1.45 1.59 <0.001 1.19 1.44 1.71 <0.001
Energy-adjusted 
vitamin E intake (mg/d) 11.8 13.0 14.2 <0.001 104.6 112.3 118.6 <0.001 12.3 13.0 13.7 <0.001
1 Adjusted for age and sex.
2 Systolic blood pressure ‡ 140 mm Hg, diastolic blood pressure ‡ 90 mm Hg, or use of antihypertensive medication.
3 A serum cholesterol concentration ‡ 6.5 mmol/L.
4 Use of either b-carotene, vitamin E, vitamin C, or multivitamin supplements.
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tertile, and of vitamin E were 7.8 mg/d in the lowest tertile and 18.5
mg/d in the highest tertile. The percentage of hypercholesterolemic
subjects was higher in the lowest tertile than in the upper 2 tertiles of
b-carotene intake. The percentage of current smokers declined signi-
ficantly across tertiles of b-carotene. A similar significant decline was
observed for the percentage of current smokers across tertiles of vita-
min C and vitamin E (Table 1). In addition, mean alcohol intake was
highest for the lowest tertiles of dietary antioxidant intake. Although
dietary antioxidant intake generally increased across tertiles of the
other antioxidants, the increase in b-carotene and vitamin C with ter-
tiles of vitamin E was modest. Spearman correlation coefficients were
highest between b-carotene and vitamin C (r = 0.36, P < 0.0001) and
lowest between vitamin C and vitamin E (r = 0.12, P < 0.0001).
b-Carotene from food sources was inversely related to risk of MI
after adjustment for age and sex (Table 2). The relative risk for the
highest compared with the lowest tertile was 0.55 (95% CI: 0.34, 0.86;
P for trend = 0.009). After additional adjustment for BMI, pack-years,
equivalent household income, education level, and alcohol intake, the
observed association remained (Table 2). Further adjustment for vita-
min E and vitamin C did not alter the observed association. To evalu-
ate whether the observed association of b-carotene from food sources
was independent of antioxidative vitamin supplementation, antioxi-
dant vitamin supplement use (b-carotene, vitamin C, vitamin E, or
multivitamins) was included in the multivariate model. The relative
risk of MI for antioxidant vitamin supplement users compared with
nonusers was 0.49 (95% CI: 0.21, 0.99; P = 0.008). The relative risk
of the highest compared with the lowest tertile of b-carotene intake
was 0.55 (95% CI: 0.34, 0.85; P for trend = 0.013). Further adjustment
for dietary fats and cholesterol did not change the observed associa-
tion. When b-carotene intakes from food sources and supplements
were considered simultaneously, the age- and sex-adjusted relative risk
was 0.49 (95% CI: 0.31, 0.86; P for trend = 0.019) for the highest com-
pared with the lowest tertile of b-carotene consumption. Multivariate
adjustment led to only slight changes in the point estimate (highest
compared with lowest tertile: relative risk, 0.50; 95% CI: 0.31, 0.82; P
for trend = 0.006).
The association between dietary b-carotene and the risk of MI
differed significantly on the basis of baseline smoking status. We
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TABLE 2
Risk of myocardial infarction (MI) and 95% CIs according to energy-adjusted tertiles of dietary b-carotene, vitamin C, and vitamin E intakes
Tertiles of dietary energy-adjusted intake P value 
Variable 1 (lowest)1 (n = 1601) 2 (n = 1601) 3 (highest) (n = 1600) for trend
b-carotene intake
Number of MIs 53 41 30
Energy-adjusted b-carotene intake (mg/d) < 1.13 1.13–1.57 > 1.57
Relative risk (95% CI)
Age and sex adjusted 1.00 0.74 (0.48, 1.12) 0.55 (0.34, 0.86) 0.009
Multivariate adjusted 12 1.00 0.74 (0.48, 1.12) 0.57 (0.36, 0.91) 0.017
Multivariate adjusted 23 1.00 0.72 (0.47, 1.10) 0.55 (0.34, 0.83) 0.013
Vitamin E intake
Number of MIs 33 49 42
Energy-adjusted vitamin E intake (mg/d) < 10.2 10.2–14.2 > 14.2
Relative risk (95% CI)
Age and sex adjusted 1.00 1.41 (0.90, 2.23) 1.05 (0.66, 1.69) 0.916
Multivariate adjusted 12 1.00 1.40 (0.90, 2.22) 1.07 (0.67, 1.73) 0.836
Multivariate adjusted 23 1.00 1.52 (0.97, 2.42) 1.21 (0.75, 1.98) 0.528
Vitamin C intake
Number of MIs 47 41 36
Energy-adjusted vitamin C intake (mg/d) < 87 87–126 > 126
Relative risk (95% CI)
Age and sex adjusted 1.00 0.89 (0.58, 1.37) 0.84 (0.54, 1.30) 0.446
Multivariate adjusted12 1.00 0.94 (0.58, 1.37) 0.88 (0.56, 1.38) 0.581
Multivariate adjusted 23 1.00 1.01 (0.65, 1.56) 1.05 (0.65, 1.67) 0.856
1 Reference category.
2 Adjusted for age, sex, body mass index, pack-years, equivalent household income (5 categories), education (5 categories), and alcohol intake (5 cate-
gories).
3 Adjusted for age, sex, body mass index, pack-years, equivalent household income (5 categories), education (5 categories), alcohol intake (5 categories),
use of antioxidative vitamin supplements, and categories of energy-adjusted b-carotene, vitamin C, and vitamin E intakes.
TABLE 3
Tertiles of energy-adjusted dietary b-carotene intake and risk of myocardial infarction (95% CIs) according to smoking status1
Tertiles of energy-adjusted dietary b-carotene intake
1 (lowest)2 2 3 (highest) P value
Variable <1.13 mg/d 1.13–1.57 mg/d >1.57 mg/d for trend
Current smokers (n = 1133) 1.00 0.87 (0.42, 1.83) 0.45 (0.17, 1.10) 0.058
Former smokers (n = 1984) 1.00 0.53 (0.27, 1.01) 0.32 (0.14, 0.66) 0.002
Nonsmokers (n = 1685) 1.00 1.00 (0.39, 2.55) 1.68 (0.65, 4.39) 0.299
1 The multivariate-adjusted model was adjusted for age, sex, body mass index, pack-years, equivalent household income (5 categories), education (5 cat-
egories), alcohol intake (5 categories), categories of energy-adjusted vitamin C and vitamin E, and antioxidative vitamin supplementation.
2 Reference category.
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observed a significant inverse association between b-carotene
intakes and risk of MI in former smokers and a nonsignificant
inverse association among current smokers (Table 3). No interac-
tion between b-carotene intakes and smoking status was observed.
These associations were the same when b-carotene intakes from
food and supplements were considered simultaneously. We did not
observe an association between tertiles of dietary vitamin C intake
and risk of MI in an age- and sex-adjusted model (Table 2). In addi-
tion, no association with risk of MI was observed for tertiles of vit-
amin E. Stratification by smoking status did not alter these results.
DISCUSSION
In the elderly cohort of the Rotterdam Study, we observed an
inverse association of b-carotene intake with risk of MI, indepen-
dent of antioxidative vitamin supplement use. The association
observed was most evident in former and current smokers. Dietary
vitamin C and vitamin E were not associated with risk of MI.
Before these results can be interpreted, some methodologic
issues should be considered. Potential bias due to incomplete
follow-up was unlikely to have occurred because the follow-up
rate was high (94%). Ascertainment of cases was facilitated by
the close cooperation with GPs in the study district of Ommo-
ord and linkage to the municipal health service of Rotterdam.
Because all events were classified independently by 2 research
physicians and subsequently by a cardiovascular disease expert,
inaccuracies in diagnosis coding were minimized. Because sub-
jects with a previous diagnosis of MI may have altered their diet
as a consequence of the disease, subjects reporting hospitaliza-
tion for MI at baseline were excluded from the analysis.
Certain methodologic issues may have weakened the
observed association between dietary antioxidant vitamin use
and risk of MI. A serious limitation of studies addressing diet
are inaccuracies in the determination of intakes. Random mis-
classification of dietary habits may decrease the ability to detect
associations between diet and disease, as do changes in dietary
habits during the follow-up period. The observed weak correla-
tion between dietary vitamin intake and bioavailability may
have further diluted the observed associations between dietary
antioxidants and disease, eg, MI. Insufficient heterogeneity of
dietary intake in the population may make it more difficult to
detect diet-disease associations. In the present study, contrasts
in the range of dietary intake between the lowest and the high-
est tertiles were modest for b-carotene, vitamin E, and vitamin
C; ie, the between-person variation was low. In addition, b-
carotene, vitamin E, and vitamin C supplements were only used
by a small proportion of the population: 0.6% used b-carotene,
1.4% used vitamin E, and 5.7% used vitamin C. Inclusion of
supplemental dietary intakes somewhat strengthened the associ-
ation between b-carotene intake and risk of MI.
Observational studies have indicated that b-carotene may exert
a protective effect against ischemic heart disease, although the
evidence is not conclusive (10). Studies focusing on b-carotene in
plasma or adipose tissue, however, yielded consistent results in
general. Biologically plausible mechanisms such as the potential
of antioxidants to scavenge free radicals (17) and the ability of
antioxidants to inhibit lipid peroxidation (18, 19) support these
findings, although the latter mechanism remains controversial
(20, 21). In middle-aged populations, subjects with low plasma b-
carotene concentrations were found to have an elevated risk of
angina pectoris (1) and MI (22); however, MI appeared to be lim-
ited to smokers with low serum b-carotene concentrations. Risk
of MI was also considerably elevated in current smokers with low
b-carotene concentrations in adipose tissue (23). In contrast,
there was an inverse association between total plasma carotenoid
concentrations and risk of fatal ischemic heart disease and nonfa-
tal MI in nonsmoking hyperlipidemic men (24). Studies focusing
on the elderly showed either no association between carotenoid
concentrations and dietary intake and the risk of ischemic heart
disease (7) or an inverse association between intake of carotene-
containing fruit and vegetables and the risk of cardiac death due
to MI and ischemic heart disease (5). In the present study, we
observed a significant protective effect of b-carotene intakes
against the risk of MI in the elderly population of the Rotterdam
Study, which was most evident in current and former smokers.
The effects of b-carotene in our study and other observational
studies are at odds with recent findings from large supplement
intervention trials of chronic disease prevention (25–29). These
trials reported either no effect of b-carotene supplementation on
the incidence of cardiovascular disease (29) or a slight increase in
cardiovascular mortality (25, 27–29). However, only one of these
trials was designed to address cardiovascular disease in particular
(26). Several explanations have been proposed to explain the dis-
parity between results obtained by observational and intervention
studies. The duration and dosage of b-carotene may have been
inadequate (30, 31) and b-carotene may have been administered
too late in the carcinogenic or atherogenic process to be of bene-
fit. (A protective effect of b-carotene may be most beneficial in
the early phase of the carcinogenic or atherosclerotic process.)
Adverse effects of supplemental b-carotene on plasma concentra-
tions of other carotenoids have been reported (32, 33) and there is
limited evidence that b-carotene could function as a prooxidant at
higher concentrations (30). The associations found, however, can-
not be ascribed to b-carotene exclusively. Possibly, b-carotene is
a marker for some other substance in b-carotene–containing
foods or for dietary patterns and lifestyle behavior closely linked
to a diet rich in vegetables and fruit that is associated with
reduced risk of ischemic heart disease. A habitual diet rich in b-
carotene–containing products may thus also protect against
ischemic heart disease in the elderly.
In the present study, we did not observe an association between
dietary vitamin C and risk of MI. Our results agree with those of
several other studies that did not find vitamin C to be associated
with a protective effect against ischemic heart disease, as summa-
rized by Jha et al (10). In studies in the elderly, some investigators
observed an inverse association between cardiovascular diseases
and high dietary vitamin C intakes and high plasma vitamin C con-
centrations (7), whereas others observed no association between
cardiovascular diseases and high dietary vitamin C intakes and high
plasma vitamin C concentrations (34) or use of vitamin C supple-
ments (9). Results of a Finnish study linking vitamin C deficiency
to an increased risk of MI (35) suggest that suboptimal vitamin C
concentrations elevate the risk of MI. These findings are supported
by experimental data showing that lipid peroxidation is detectable
only after all ascorbate has been completely used up (36).
The most consistent, reliable, published beneficial effects of
antioxidants on fatal and nonfatal cardiovascular diseases in
middle-aged populations have been observed with vitamin E.
These effects have been noted after both supplement use and rel-
atively high dietary intakes (1, 4, 8, 37) sustained for ‡ 2 y (2, 3).
The relative risk reduction for various cardiovascular endpoints
ranged from 31% to 65% (10). In the present study, however, we
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did not observe an association between dietary vitamin E intakes
and reduced risk of MI. This finding is consistent with the find-
ings of most studies that investigated the association between
dietary vitamin E intakes and plasma vitamin E concentrations
and risk of heart disease mortality in the elderly (7). Only one
study observed an inverse association of vitamin E supplementa-
tion on ischemic heart disease risk in the elderly (9).
In summary, we found an inverse association between high
dietary b-carotene intakes and risk of MI in an elderly popula-
tion. Whether this association may be ascribed to b-carotene
exclusively, to a diet rich in b-carotene–containing products, or
to dietary patterns and lifestyle behavior closely linked to a diet
rich in vegetables and fruit remains to be elucidated.
We are grateful to the participants of the Rotterdam Study, all fieldwork-
ers and dietitians in the Ommoord Research Center for their enthusiasm and
skillful contributions, the participating general practitioners of the Rotterdam
Study, and the research physicians of the Rotterdam Study for their commit-
ment in collecting follow-up information.
REFERENCES
1. Riemersma RA, Wood DA, MacInytre CCA, Elton RA, Gey KF, Oliver
MF. Risk of angina pectoris and plasma concentrations of vitamins A, C,
and E and carotene. Lancet 1991;337:1–5.
2. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Wil-
lett WC. Vitamin E consumption and the risk of coronary disease in
women. N Engl J Med 1993;328:1444–9.
3. Rimm EB, Stampfer MJ, Ascherio A, Giovanucci E, Colditz GA, Wil-
lett WC. Vitamin E consumption and the risk of coronary heart disease
in men. N Engl J Med 1993;328:1450–6.
4. Knekt P, Reunanen A, Järvinen R, Seppänen R, Heliövaara M, Aromaa
A. Antioxidant vitamin intake and coronary mortality in a longitudinal
population study. Am J Epidemiol 1994;139:1180–9.
5. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, Buring
JE. A prospective study of consumption of carotenoids in fruits and veg-
etables and decreased cardiovascular mortality in the elderly. Ann Epi-
demiol 1995;5:255–60.
6. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vit-
amin C and b-carotene and risk of death in middle-aged men. The West-
ern Electric Study. Am J Epidemiol 1995;142:1269–78.
7. Sahyoun NR, Jaques PF, Russell RM. Carotenoids, vitamins C and E,
and mortality in an elderly population. Am J Epidemiol 1996;
144:501–11.
8. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary
antioxidant vitamins and death from coronary heart disease in post-
menopausal women. N Engl J Med 1996;334:1156–62.
9. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supple-
ment use and risk of all-cause and coronary heart disease mortality in
older persons: the Established Populations for Epidemiologic Studies of
the Elderly. Am J Clin Nutr 1996;64:190–6.
10. Jha P, Flather M, Lonn E, Farkouth M, Yusuf S. The antioxidant vita-
mins and cardiovascular disease. A critical review of epidemiologic and
clinical trial data. Ann Intern Med 1995;123:860–72.
11. Hofman A, Grobbee DE, De Jong PTVM, Vandenouweland FA. Deter-
minants of disease and disability in the elderly: The Rotterdam Elderly
Study. Eur J Epidemiol 1991;7:403–22.
12. WHO. International statistical classification of diseases and related
health problems. 10th ed. Geneva: WHO, 1992.
13. Voedingsraad. NEVO tabel. Nederlands Voedingstoffenbestand. (NEVO
table. Dutch nutrient database.) Den Haag: Voorlichtingsbureau voor de
Voeding, 1993 (in Dutch).
14. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary
assessment in the elderly: validation of a semiquantitative food fre-
quency questionnaire. Eur J Clin Nutr 1998;52:588–96.
15. Willett WC, Stampfer MJ. Total energy intake: implications for epi-
demiologic analysis. Am J Epidemiology 1986;124:17–27.
16. Beaton GH, Milner J, Corey P, et al. Sources of variance in 24-hour
dietary recall data: implications for nutrition study design and interpre-
tation. Am J Clin Nutr 1979;32:2546–59.
17. Krinksy NI. Antioxidant functions of carotenoids. Free Radic Biol Med
1989;7:617–35.
18. Jilial I, Norkus EP, Cristol L, Grundy SM. b-carotene inhibits the oxida-
tive modification of low-density lipoprotein. Biochim Biophys Acta
1991;1086:134–8.
19. Tsuchihashi H, Kigoshi M, Iwatsuki M, Niki E. Action of b-carotene as
an antioxidant against lipid peroxidation. Arch Biochem Biophys
1995;323:137–47.
20. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of
dietary antioxidant combinations in humans. Protection of LDL by vit-
amin E but not by b-carotene. Arterioscler Thromb 1993;13:590–600.
21. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Sup-
plementation with vitamin E but not b-carotene in vivo protects low
density lipoprotein peroxidation in vitro. Effect of cigarette smoking.
Arterioscler Thromb 1992;12:554–62.
22. Street DA, Comstock GW, Salkeld RM, Shuep W, Klag M. A popula-
tion-based case-control study of the association of serum antioxidants
and myocardial infarction. Am J Epidemiol 1991;134:719–20.
23. Kardinaal AF, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue
and risk of myocardial infarction. Lancet 1993;342:1379–84.
24. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary
heart disease. The Lipid Research Clinics Coronary Primary Prevention
Trial and Follow-up Study. JAMA 1994;272: 1439–41.
25. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The
effect of vitamin E and beta-carotene on the incidence of lung cancer
and other cancers in male smokers. N Engl J Med 1994; 330:1029–35.
26. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term
supplementation with beta-carotene on the incidence of malignant neo-
plasms and cardiovascular disease. N Engl J Med 1996; 334:1145–9.
27. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combina-
tion of beta carotene and vitamin A on lung cancer and cardiovascular
disease. N Engl J Med 1996;334:1150–5.
28. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with
low plasma concentration of beta-carotene and the effect of oral supple-
mentation. JAMA 1996;275:699–703.
29. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-toco-
pherol and b-carotene supplements on incidence of major coronary
events in men with previous myocardial infarction. Lancet
1997;349:1715–20.
30. Rautalahti M, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Heinonen
OP. Beta-carotene did not work: aftermath of the ABTC study. Cancer
Lett 1997;114:235–6.
31. Mayne ST. Beta-carotene, carotenoids, and disease prevention in
humans. FASEB J 1996;10:690–701.
32. Micozzi MS, Brown ED, Edwards BK, et al. Plasma carotenoid
response to chronic intake of selected foods and b-carotene supplements
in men. Am J Clin Nutr 1992;55:1120–5.
33. Goodman GE, Thornquist M, Kestin M, et al. The association between
participant characteristics and serum concentrations of b-carotene,
retinol, retinyl palmitate, and alpha-tocopherol among participants in the
Carotene and Retinol Efficacy Trial (CARET) for prevention of lung
cancer. Cancer Epidemiol Biomarkers Prev 1996;5:815–21.
34. Gale CR, Martyn CN, Winter P, Cooper C. Vitamin C and risk of death
from stroke and coronary heart disease in a cohort of elderly people. Br
Med J 1995;310:1563–6.
35. Nyyssönen K, Parvianinen MT, Salonen R, Tuomilehto J, Salonen JT.
Vitamin C deficiency and risk of myocardial infarction: prospective
population study of men from eastern Finland. BMJ 1997; 314:634–8.
36. Retsky KL, Frei B. Vitamin C prevents metal ion-dependent initia-
tion and propagation of lipid peroxidation in human low-density
lipoprotein. Biochim Biophys 1995;1257:279–87.
37. Stephens NG, Parsons A, Schofield PM, et al. Randomised con-
trolled trial of vitamin E in patients with coronary disease: Cam-
bridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781–6.
266 KLIPSTEIN-GROBUSCH ET AL
 at Swets Subscription Service 76130274 on Decem
ber 6, 2006 
w
w
w
.ajcn.org
D
ow
nloaded from
 
